![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0178.jpg)
A Cost-Effective Tool
Comparison of 10-12 core TRUSGB to mpMRI & mRI
guided biopsy
Comparable costs but with higher QoL
Expected costs per patient: 2423 euros (MRI) vs 2392
(TRUS-GB)
Corresponding QALYs (quality adjusted life years) higher
for MRI strategy : incremental cost-effectiveness ratio of
323 euros per QALY
Rooij et al. Eur Urol 2014; 66 (2014) 430–436